267 related articles for article (PubMed ID: 18487478)
1. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes.
Abdul-Ghani MA; Abdul-Ghani T; Ali N; Defronzo RA
Diabetes Care; 2008 Aug; 31(8):1650-5. PubMed ID: 18487478
[TBL] [Abstract][Full Text] [Related]
2. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study.
Abdul-Ghani MA; Lyssenko V; Tuomi T; DeFronzo RA; Groop L
Diabetes Care; 2009 Feb; 32(2):281-6. PubMed ID: 19017778
[TBL] [Abstract][Full Text] [Related]
3. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
[TBL] [Abstract][Full Text] [Related]
4. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
5. What is the best predictor of future type 2 diabetes?
Abdul-Ghani MA; Williams K; DeFronzo RA; Stern M
Diabetes Care; 2007 Jun; 30(6):1544-8. PubMed ID: 17384342
[TBL] [Abstract][Full Text] [Related]
6. Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge.
Haeckel R; Raber R; Wosniok W
Clin Chem Lab Med; 2006; 44(12):1462-71. PubMed ID: 17163824
[TBL] [Abstract][Full Text] [Related]
7. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
Gonzélez C; Stern MP; Mitchell BD; Valdez RA; Haffner SM; Pérez BA
Diabetes Care; 1994 May; 17(5):397-404. PubMed ID: 8062606
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
Lorenzo C; Okoloise M; Williams K; Stern MP; Haffner SM;
Diabetes Care; 2003 Nov; 26(11):3153-9. PubMed ID: 14578254
[TBL] [Abstract][Full Text] [Related]
10. A CROSS-SECTIONAL STUDY OF THE ASSOCIATION BETWEEN THE 1-HOUR ORAL GLUCOSE TOLERANCE TEST AND THE METABOLIC SYNDROME IN A HIGH-RISK SAMPLE WITH IMPAIRED FASTING GLUCOSE.
Lizarzaburu-Robles JC; Torres-Aparcana L; Mansilla R; Valera J; Vargas G; Vento F; Laca J; Cornetero V; Herman WH
Endocr Pract; 2020 May; 26(5):529-534. PubMed ID: 31968195
[No Abstract] [Full Text] [Related]
11. Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk.
Defronzo RA; Tripathy D; Schwenke DC; Banerji M; Bray GA; Buchanan TA; Clement SC; Henry RR; Kitabchi AE; Mudaliar S; Ratner RE; Stentz FB; Musi N; Reaven PD; Gastaldelli A;
Diabetes Care; 2013 Nov; 36(11):3607-12. PubMed ID: 24062330
[TBL] [Abstract][Full Text] [Related]
12. Association between metabolic syndrome and carotid atherosclerosis in individuals without diabetes based on the oral glucose tolerance test.
Ishizaka N; Ishizaka Y; Yamakado M; Toda E; Koike K; Nagai R
Atherosclerosis; 2009 Jun; 204(2):619-23. PubMed ID: 19056083
[TBL] [Abstract][Full Text] [Related]
13. Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose.
Abdul-Ghani MA; Stern MP; Lyssenko V; Tuomi T; Groop L; Defronzo RA
Diabetes Care; 2010 Mar; 33(3):557-61. PubMed ID: 20007945
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of type II diabetes mellitus in population of Krakow].
Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
[TBL] [Abstract][Full Text] [Related]
15. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.
Osei K; Rhinesmith S; Gaillard T; Schuster D
Diabetes Care; 2004 Jun; 27(6):1439-46. PubMed ID: 15161801
[TBL] [Abstract][Full Text] [Related]
16. Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.
Mori Y; Hoshino K; Yokota K; Yokose T; Tajima N
Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):334-9. PubMed ID: 15977101
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
Meis SB; Schuster D; Gaillard T; Osei K
Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
[TBL] [Abstract][Full Text] [Related]
18. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes.
Chou P; Li CL; Wu GS; Tsai ST
Diabetes Care; 1998 Jul; 21(7):1183-7. PubMed ID: 9653617
[TBL] [Abstract][Full Text] [Related]
19. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?
Stern MP; Williams K; Haffner SM
Ann Intern Med; 2002 Apr; 136(8):575-81. PubMed ID: 11955025
[TBL] [Abstract][Full Text] [Related]
20. 1-hour venous plasma glucose and incident prediabetes and diabetes in Asian indians.
Priya M; Anjana RM; Chiwanga FS; Gokulakrishnan K; Deepa M; Mohan V
Diabetes Technol Ther; 2013 Jun; 15(6):497-502. PubMed ID: 23550555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
